Asia-Pacific Americas Africa Europe Middle East

HETERO DRUGS

Company Profile:

HETERO DRUGS Company Profile

HETERO DRUGS is primarily a MANUFACTURER.

Hetero Drugs Limited is one of India's leading research-based pharmaceutical companies. Headquartered in Hyderabad, India, it was established in 1993. Hetero is recognized globally as a vertically integrated pharmaceutical organization, engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, and finished dosage formulations.

The company is one of the world's largest producers of anti-retroviral drugs, playing a significant role in the treatment of HIV/AIDS. Beyond anti-retrovirals, Hetero's extensive product portfolio spans various therapeutic areas including oncology, neuroscience, cardiovascular, dermatology, nephrology, urology, pain management, and immunology.

Hetero operates numerous state-of-the-art manufacturing facilities, many of which are approved by stringent global regulatory authorities such as the US FDA, EU GMP, and others. The company has a strong focus on research and development, continuously innovating to bring affordable and accessible medicines to patients worldwide. Its products are marketed in over 120 countries, establishing a significant global presence.

In summary, Hetero Drugs is a prominent pharmaceutical manufacturer with a strong emphasis on R&D, large-scale production of APIs and formulations, and a broad international reach.

Enterprise Products

Hetero Drugs, an Indian pharmaceutical company, manufactures and sells a wide range of products, including Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs), across various therapeutic areas. Their product portfolio includes:

Antivirals:

Remdesivir

Favipiravir

Molnupiravir

Tenofovir

Efavirenz

Dolutegravir

Sofosbuvir

Daclatasvir

Ledipasvir

Oncology:

Bortezomib

Pemetrexed

Lenalidomide

Imatinib

Dasatinib

Nilotinib

Erlotinib

Gefitinib

Sorafenib

Cardiovascular:

Rosuvastatin

Atorvastatin

Telmisartan

Amlodipine

Valsartan

Metoprolol

Diabetes:

Metformin

Glimepiride

Voglibose

Pioglitazone

Gliclazide

Central Nervous System (CNS):

Escitalopram

Olanzapine

Quetiapine

Risperidone

Gastroenterology:

Pantoprazole

Rabeprazole

Ondansetron

Domperidone

Itopride

Pain and Inflammation:

Etoricoxib

Celecoxib

Diclofenac

Aceclofenac

Paracetamol

Anti-infectives:

Cefixime

Azithromycin

Levofloxacin

Moxifloxacin

Fluconazole

Respiratory:

Montelukast

Salbutamol

Budesonide

Formoterol

Nephrology:

Mycophenolate Mofetil

Tacrolimus

Immunology:

Rituximab (biosimilar)

This list provides a representative overview and is not exhaustive, as Hetero Drugs has a vast and continuously expanding product line.

Business Registration Information:

Manager:

Dr. B. Partha Saradhi Reddy

Phone:

No Data

E-mail:

investorrelations@hetero.com

Official Website:
Address:

Hetero Corporate, 7-2-A2, Industrial Estate, Sanath Nagar, Hyderabad – 500 018, Telangana, India.

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.